| Quarter (USD) | Sep 24 | Jun 24 | Mar 24 | Dec 23 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
|---|---|---|---|---|---|---|
| Cash on hand (at last report) | 16.17 mm | 16.17 mm | 16.17 mm | 16.17 mm | 16.17 mm | 16.17 mm |
| Cash burn (monthly) | (no burn) | 290.17 k | 10.86 mm | 13.32 mm | 8.46 mm | 10.80 mm |
| Cash used (since last report) | n/a | 1.47 mm | 55.16 mm | 67.70 mm | 42.98 mm | 54.86 mm |
| Cash remaining | n/a | 14.69 mm | -38.99 mm | -51.53 mm | -26.81 mm | -38.69 mm |
| Runway (months of cash) | n/a | 50.6 | -3.6 | -3.9 | -3.2 | -3.6 |
| 13F holders | Current |
|---|---|
| Total holders | 99 |
| Opened positions | 21 |
| Closed positions | 37 |
| Increased positions | 40 |
| Reduced positions | 21 |
| 13F shares | Current |
|---|---|
| Total value | 81.84 bn |
| Total shares | 62.17 mm |
| Total puts | 17.40 k |
| Total calls | 133.70 k |
| Total put/call ratio | 0.1 |
| Largest owners | Shares | Value |
|---|---|---|
| venBio Partners | 9.70 mm | $17.65 bn |
| FMR | 5.87 mm | $10.67 bn |
| venBio Global Strategic Fund II | 5.27 mm | $162.11 mm |
| Tang Capital Management | 4.20 mm | $7.65 bn |
| Tang Capital Partners | 4.04 mm | $9.41 mm |
| Vivo Capital | 4.03 mm | $7.34 bn |
| Vivo Capital IX | 4.03 mm | $124.14 mm |
| Redmile | 3.84 mm | $6.98 bn |
| BlackRock | 2.60 mm | $4.74 bn |
| MPM Oncology Impact Management | 2.41 mm | $4.39 bn |
| Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 19 Feb 25 | Lettmann Jason | Common Stock | Sell | Dispose S | No | No | 1.1502 | 2,159 | 2.48 k | 170,270 |
| 19 Feb 25 | Jaume Pons | Common Stock | Sell | Dispose S | No | No | 1.1502 | 1,326 | 1.53 k | 579,388 |
| 19 Feb 25 | Shelly Pinto | Common Stock | Sell | Dispose S | No | No | 1.1502 | 550 | 632.61 | 87,352 |
| 21 Jan 25 | Lettmann Jason | Employee Stock Option Common Stock | Grant | Acquire A | No | No | 1.65 | 478,000 | 788.70 k | 478,000 |
| 21 Jan 25 | Jaume Pons | Employee Stock Option Common Stock | Grant | Acquire A | No | No | 1.65 | 50,000 | 82.50 k | 50,000 |
